Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 2575 of 3499 entries
View as:

Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00001937 Org: User:
Start: 11/30/99 End: 12/31/00 Due: 12/31/01

The Impact of Starbright World on Children Being Treated at the NIH

Phase: N/A Priority: Normal
NCT ID: NCT00001816 Org: User:
Start: 05/31/99 End: 02/28/01 Due: 02/28/02

Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00138177 Org: User:
Start: 07/31/05 End: - Due: -

Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01856322 Org: User:
Start: 04/30/13 End: 01/31/15 Due: 01/31/16

Erlotinib Hydrochloride in Treating Patients With Bladder Cancer Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02169284 Org: User:
Start: 10/01/14 End: 03/30/18 Due: 03/30/19

Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00923936 Org: User:
Start: 04/23/09 End: 11/08/17 Due: 11/08/18

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

Phase: N/A Priority: Normal
NCT ID: NCT03531814 Org: User:
Start: 10/23/18 End: 03/20/23 Due: 03/20/24

A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage

Phase: N/A Priority: Normal
NCT ID: NCT00887159 Org: User:
Start: 07/16/09 End: 11/15/16 Due: 11/15/17

Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00001435 Org: User:
Start: 04/30/95 End: 12/31/00 Due: 12/31/01

Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

Phase: N/A Priority: Normal
NCT ID: NCT05411107 Org: User:
Start: 06/01/24 End: 06/30/27 Due: 06/30/28

Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003869 Org: User:
Start: 04/30/99 End: 05/31/08 Due: 05/31/09

Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00001560 Org: User:
Start: 12/24/96 End: 10/31/11 Due: 10/31/12

Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion

Phase: N/A Priority: Normal
NCT ID: NCT02581137 Org: User:
Start: 06/10/16 End: 12/20/25 Due: 12/20/26

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Phase: N/A Priority: Normal
NCT ID: NCT06195306 Org: User:
Start: 04/01/25 End: 01/01/28 Due: 01/01/29

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

Phase: N/A Priority: Normal
NCT ID: NCT04216290 Org: User:
Start: 03/17/21 End: 06/30/26 Due: 06/30/27

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00602459 Org: User:
Start: 01/15/08 End: 04/15/23 Due: 04/15/24

Bevacizumab and Cetuximab With or Without Irinotecan in Treating Patients With Irinotecan-Refractory Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00077298 Org: User:
Start: 12/31/03 End: 07/31/07 Due: 07/31/08

Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory and That Expresses E-selectin Ligand on the Cell Membrane

Phase: N/A Priority: Normal
NCT ID: NCT05146739 Org: User:
Start: 10/10/23 End: 05/09/26 Due: 05/09/27

Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT04195555 Org: User:
Start: 07/20/20 End: 05/09/26 Due: 05/09/27

IFNL4 Genotype for Predicting Response to Ledipasvir/Sofosbuvir

Phase: N/A Priority: Normal
NCT ID: NCT03639207 Org: User:
Start: 06/15/18 End: 07/03/19 Due: 07/03/20

Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT00906360 Org: User:
Start: 07/31/08 End: - Due: -

Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00244972 Org: User:
Start: 10/31/05 End: 03/31/17 Due: 03/31/18

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02598557 Org: User:
Start: 12/06/16 End: 02/02/23 Due: 02/02/24

Immunotoxin in Treating Patients With Leukemia or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00002765 Org: User:
Start: 04/30/96 End: - Due: -

Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00923884 Org: User:
Start: 03/18/09 End: 04/20/18 Due: 04/20/19